Spots Global Cancer Trial Database for A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
Official Title: A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
Study ID: NCT01838317
Conditions
Interventions
Study Description
Brief Summary: This study is being done to determine whether or not addition of the oral medication, pioglitazone to standard chemotherapy, results in improvement of blood tests that measure the body's ability to utilize sugar (glucose and insulin metabolism). In addition the investigators want to determine whether or not treatment with pioglitazone results in (1) improvement in the size of the tumor, (2) weight gain, (3) improved ability to function during the day and (4) quality of life.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UT Southwestern Medical Center, Dallas, Texas, United States
Contact Details
Name: Muhammad Beg, MD
Affiliation: UT Southwestern Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
